These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20978734)

  • 1. [Vaccination against pneumococci and influenza. How good is the evidence?].
    Babouee B; Widmer AF; Battegay M
    Internist (Berl); 2011 Mar; 52(3):265-76. PubMed ID: 20978734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pneumococcal vaccination for children and adults].
    Albrich W
    Ther Umsch; 2016; 73(5):235-40. PubMed ID: 27268445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of mortality and pneumonia among nursing home older adults by dual pneumococcal and seasonal influenza vaccination during a pandemic caused by novel pandemic influenza A (H1N1).
    Chan TC; Hung IF; Luk JK; Shea YF; Chan FH; Woo PC; Chu LW
    J Am Med Dir Assoc; 2012 Oct; 13(8):698-703. PubMed ID: 22722051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccinations from the pulmonologist's point of view].
    Forstner C; Pletz MW
    Internist (Berl); 2015 Jul; 56(7):838-46. PubMed ID: 26059891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching.
    Song JY; Noh JY; Lee JS; Wie SH; Kim YK; Lee J; Jeong HW; Kim SW; Lee SH; Park KH; Choi WS; Cheong HJ; Kim WJ
    PLoS One; 2018; 13(12):e0207918. PubMed ID: 30521553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab.
    Berglund A; Willén L; Grödeberg L; Skattum L; Hagberg H; Pauksens K
    Acta Oncol; 2014 Sep; 53(9):1212-20. PubMed ID: 24865118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives.
    Wagner A; Weinberger B
    Front Immunol; 2020; 11():717. PubMed ID: 32391017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccinations in respiratory medicine].
    Lode HM; Stahlmann R
    HNO; 2015 Sep; 63(9):649-59; quiz 659-60. PubMed ID: 26330051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New vaccines for the prevention of pneumococcal infections.
    Käyhty H; Eskola J
    Emerg Infect Dis; 1996; 2(4):289-98. PubMed ID: 8969245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.
    Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
    Vaccine; 2017 Aug; 35(36):4806-4810. PubMed ID: 28818473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reasons for adult immunization -- prevention of most frequent respiratory infections].
    Ludwig E
    Orv Hetil; 2014 Nov; 155(44):1743-7. PubMed ID: 25344851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influenza and pneumococcal vaccination in adults].
    Weinke T; Güthoff W
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S82-5. PubMed ID: 19353477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.
    Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Saez M; Soldevila N; Astray J; Mayoral JM; Martín V; Quintana JM; González-Candelas F; Galán JC; Tamames S; Castro A; Baricot M; Garín O; Pumarola T;
    Hum Vaccin Immunother; 2013 Apr; 9(4):865-73. PubMed ID: 23563516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study.
    Suzuki K; Kondo K; Washio M; Nakashima K; Kan S; Imai S; Yoshimura K; Ota C; Ohfuji S; Fukushima W; Hirota Y
    Hum Vaccin Immunother; 2019; 15(9):2171-2177. PubMed ID: 30785356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis.
    Zhang YY; Tang XF; Du CH; Wang BB; Bi ZW; Dong BR
    Hum Vaccin Immunother; 2016 Dec; 12(12):3056-3064. PubMed ID: 27629584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older.
    Honkanen PO; Keistinen T; Miettinen L; Herva E; Sankilampi U; Läärä E; Leinonen M; Kivelä SL; Mäkelä PH
    Vaccine; 1999 Jun; 17(20-21):2493-500. PubMed ID: 10418894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of influenza and 23-valent pneumococcal polysaccharide vaccinations on elderly with chronic obstructive pulmonary diseases: a community-based intervention study].
    Wen Y; He L; Zhai Y; Wu J; Chen YY; Wang H; Zong QQ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):792-798. PubMed ID: 29936749
    [No Abstract]   [Full Text] [Related]  

  • 18. The burden of severe pneumococcal infection in Ireland: potential effectiveness and indirect benefits of the 7-valent pneumococcal conjugate vaccine.
    McCormack S; McIntosh ED
    Ir Med J; 2004 Oct; 97(9):278-80. PubMed ID: 15568587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination is worthwhile - also in advanced age].
    MMW Fortschr Med; 2013 Jan; 155(1):26. PubMed ID: 23573713
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial.
    Nakashima K; Aoshima M; Ohfuji S; Yamawaki S; Nemoto M; Hasegawa S; Noma S; Misawa M; Hosokawa N; Yaegashi M; Otsuka Y
    Hum Vaccin Immunother; 2018; 14(8):1923-1930. PubMed ID: 29561248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.